Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
2026 · 1st Quarter (Jan 1 - Mar 31)
SURESCRIPTS
Filed by MCDERMOTT WILL & SCHULTE LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 13, 2026
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- MCDERMOTT WILL & SCHULTE LLP
- Client
- SURESCRIPTS
- Filing UUID
- 95b25483-2dc8-4f54-9fc9-75d46a23b5a3
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote access to pharmacist services, including H.R. 3164 and S. 2426, the Equitable Community Access to Pharmacist Services Act.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.